XML 45 R39.htm IDEA: XBRL DOCUMENT v3.24.0.1
Reverse Recapitalization -Additional Information (Details) - USD ($)
3 Months Ended 12 Months Ended
Oct. 31, 2023
Jan. 31, 2024
Oct. 31, 2023
Jun. 30, 2021
Equity, Class of Treasury Stock [Line Items]        
Common stock shares outstanding 23,197,976 23,197,976 23,197,976  
Warrants outstanding 10,411,641 10,474,054 10,411,641 10,242,130
Common stock shares issued 23,197,976 23,197,976 23,197,976  
Proceeds from trust account     $ 7,363,000  
Proceeds from PIPE financing     56,892,000  
Transactions costs deferred and netted against proceeds     $ 5,086,000  
FEAC        
Equity, Class of Treasury Stock [Line Items]        
Common stock shares outstanding 3,670,927   3,670,927  
Warrants outstanding 5,029,444 10,411,641 5,029,444  
Proceeds from trust account     $ 7,400,000  
Merger Agreement [Member]        
Equity, Class of Treasury Stock [Line Items]        
Business combination reverse recapitalization description   On October 31, 2023 (the "Closing Date”), FEAC, Old enGene, and the Company consummated the merger pursuant to the Merger Agreement, dated as of May 16, 2023. As a result of the Reverse Recapitalization, the Company became a publicly traded company, with old enGene, a subsidiary of the Company, continuing the existing business operations.    
Merger agreement date May 16, 2023      
PIPE Financing        
Equity, Class of Treasury Stock [Line Items]        
Common stock shares outstanding 23,197,976   23,197,976  
Warrants outstanding 10,411,641   10,411,641  
Value of stock and warrant issued during the period     $ 56,900,000  
Transaction costs $ 11,100,000   11,100,000  
Transactions costs deferred and netted against proceeds     5,100,000  
PIPE Financing | FEAC        
Equity, Class of Treasury Stock [Line Items]        
Value of stock and warrant issued during the period     $ 56,900,000  
Number of new stock issued during the period     6,435,441  
Number of new warrant issued during the period     2,702,791  
Common stock, value issued     $ 56,100,000  
Warrants issued during period, value     0.8  
Proceeds from PIPE financing     56,900,000  
Transaction costs withheld from proceeds received     $ 6,000,000  
Old enGenes Equity and Convertible Note        
Equity, Class of Treasury Stock [Line Items]        
Common stock shares issued 13,091,608   13,091,608  
Old enGenes Warrant        
Equity, Class of Treasury Stock [Line Items]        
Share warrants issued 2,679,432   2,679,432  
Old enGenes Share Option        
Equity, Class of Treasury Stock [Line Items]        
Common stock shares issued   2,706,941    
Common share options issued 2,706,941   2,706,941